We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BridgeBio Pharma

News List

BridgeBio Stock Up 60% So Far In Dec., IPO Lockup Period Expires Today firstwordpharma
December 25, 2019
Shares of BridgeBio Pharma have gone up 60% so far in December, as the clinical-stage biopharmaceutical company focused on developing medicines for genetic diseases gears up for some important events in the months ahead, reported Markets Insider.
BridgeBio Pharma raises $299m to support drug R&D pharmaceutical-technology
January 25, 2019
US-based biopharmaceutical firm BridgeBio Pharma has raised $299.2m in a new financing round led by its existing investors KKR and Viking Global Investors.....
BridgeBio Pharma gets $135M for genetic disease work biospectrumasia
September 18, 2017
The company will use the cash to boost the work on its early-stage discovery and development programs, with the goal of creating genetically targeted therapeutics